This indicates that Kbtbd7 negatively regulates Vangl2 in vivo, although the increase of Vangl2 was not sufficient to induce a strong CE defect compared to high-dose Vangl2 mRNA (25, 26). The gene discussed is KBTBD7; the disease is cholesteryl ester measurement.